Destanie Florence Bankston
Family · la Marque, TXNPI 1447948138
Payments from drug & device makers
Across 137 payments — averaging $22.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$713
- Takeda Pharmaceuticals U.S.A., Inc.$565
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$300
- Pfizer$246
- Lilly USA, LLC$195
- Ipsen Biopharmaceuticals, Inc$137
- plus $965 from 15 others
What the payments were for
- Food & beverage$3,122100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 32 | $713 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $565 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 25 | $300 |
| Pfizer | 11 | $246 |
| Lilly USA, LLC | 4 | $195 |
| Ipsen Biopharmaceuticals, Inc | 6 | $137 |
| Ironwood Pharmaceuticals, Inc | 5 | $107 |
| Phathom Pharmaceuticals, Inc. | 4 | $107 |
| Cardiva Medical, Inc. | 3 | $95 |
| Gilead | 3 | $83 |
| Novo Nordisk | 4 | $78 |
| Bristol Myers Squibb | 4 | $77 |
| Celltrion USA Inc. | 3 | $76 |
| Intercept Pharmaceuticals, Inc. | 1 | $69 |
| Johnson & Johnson | 2 | $68 |
| Madrigal Pharmaceuticals | 2 | $61 |
| Ardelyx, Inc. | 2 | $39 |
| Evoke Pharma, Inc. | 2 | $31 |
| Braintree Laboratories, Inc. | 1 | $27 |
| Sanofi | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OMVOH$122
How this compares
$3,122 in reported general payments places this provider in the 85th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 99 | $5,393 |
| CholestyramineCholestyramine (With Sugar) | 31 | $1,912 |
| Omeprazole | 140 | $1,524 |
| Dicyclomine Hcl | 49 | $1,136 |
| Pantoprazole Sodium | 87 | $891 |
| Sucralfate | 66 | $884 |
| Lactulose | 25 | $343 |
| Ondansetron Hcl | 13 | $244 |
| Metronidazole | 16 | $50 |
| Famotidine | 13 | $48 |
Paid to pharmacies, not to this prescriber.
Other family in la Marque
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
- Nirupama JeromeAustin$418K
- April LopezMcAllen$417K
- Linda MercadoHouston$211K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.